Quantcast

Latest Antivirals Stories

2014-06-16 23:04:46

GIA announces the release of a comprehensive global report on Growth Factors (Blood and Tissue) markets. Global market for Growth Factors (Blood and Tissue) is forecast to reach US$48 billion by 2020, driven by growing demand for effective, cost-efficient therapeutics, and increasing significance of growth factors in the treatment of chemotherapy-associated anemia and neutropenia. San Jose, California (PRWEB) June 16, 2014 Follow us on LinkedIn – Fuelled by the growing importance of...

2014-06-13 16:23:26

NORTH CHICAGO, Ill., June 13, 2014 /PRNewswire/ -- AbbVie (NYSE: ABBV) announced today that the New Drug Application (NDA) for its investigational, all-oral, interferon-free regimen for the treatment of adult patients with chronic genotype 1 (GT1) hepatitis C virus (HCV) infection has been accepted by the U.S. Food and Drug Administration (FDA) and has been granted priority review. The NDA was submitted on April 21, 2014 and is supported by data from a large clinical program...

2014-06-11 16:27:28

ResolveHerpes is Designed to Boost the Body's Immune System and Allow it to Clear Out the Herpes Viruses HSV-1 and HSV-2 LOS ANGELES, June 11, 2014 /PRNewswire-iReach/ -- Resolve Herpes, a company that offers all-natural mineral formulations, has just announced the launch of a new and effective herpes treatment. Called ResolveHerpes, the product is designed to help boost the body's immune system, which in turn can help it naturally clear out the herpes viruses HSV-1 and HSV-2. Photo...

2014-06-09 16:25:29

EMERYVILLE, Calif., June 9, 2014 /PRNewswire/ -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), today announced that the United States Patent and Trademark Office (USPTO) issued US Patent No. 8,741,343 entitled "Method Of Administering Amantadine Prior To A Sleep Period." The claims of this patent are directed towards administration, prior to bedtime, of certain formulations of amantadine HCl, including Adamas' lead product ADS-5102 and similar amantadine-based products. "This is the...

2014-06-04 08:34:06

LONDON, June 4, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Hepatitis Drugs and Vaccines: World Market 2013-2023http://www.reportbuyer.com/pharma_healthcare/therapeutic/hepatitis_drugs_vaccines_world_market_2013_2023.html Report DetailsYour guide to sales outlooks and R&D for hepatitis treatmentsWhere are hepatitis medicines going? Visiongain's updated report predicts revenues there from 2013 to 2023. It also explains trends in that business and...

2014-06-02 23:10:38

polyDNA’s May 2014 survey revealed that 14% of elderly respondents wanted to know if a common virus could cause inflammatory bowel disease. polyDNA reviews the literature and recommends taking Gene-Eden-VIR or Novirin. Rochester, NY (PRWEB) June 02, 2014 polyDNA’s latest survey discovered that some older participants wanted to know if a common virus could cause inflammatory bowel disease. The answer is “yes.” The cytomegalovirus (CMV) can cause inflammation of the colon. This is a...

2014-05-31 23:06:42

Ultimate Herpes Protocol reviews have been flooding the Internet and have caught the attention of health writer Laura O'Connor prompting her to review the program that claims to quickly, naturally, and effectively wipe out the root cause of herpes. West Palm Beach, FL (PRWEB) May 31, 2014 The Ultimate Herpes Protocol, a natural herpes treatment created for both men and women of all age groups who are dealing with uncomfortable herpes outbreaks, has caught the attention of health...

2014-05-28 08:33:20

ROCKLAND, Mass., May 28, 2014 /PRNewswire/ -- EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, announced today that Rebif(®) (interferon beta-1a) data will be presented at the 2014 Cooperative Meeting of CMSC (Consortium of Multiple Sclerosis Centers) and ACTRIMS (Americas Committee on Research & Treatment in Multiple Sclerosis), taking place from May 28 - 31, in Dallas, TX. http://photos.prnewswire.com/prnvar/20121220/SF32295LOGO-b Data from 11 study assessments will...

2014-05-22 08:29:21

-- Submission based on the largest Phase III program in genotype 1 (GT1) hepatitis C patients conducted to date(1) -- Health Canada grants AbbVie's request for Priority Review MONTREAL, May 22, 2014 /CNW/ - AbbVie (NYSE: ABBV) filed a New Drug Submission (NDS) to Health Canada seeking approval for the company's investigational, all-oral, interferon-free regimen for the treatment of adult patients with genotype 1 (GT1) chronic hepatitis C virus (HCV) infection, including...

2014-05-20 23:18:12

In its May 2014 survey, polyDNA found that 77% of respondents wanted to know if the herpes virus can be deadly. polyDNA reviews the literature, and recommends Gene-Eden-VIR and Novirin, which have a formula proven to reduce herpes symptoms in two post-marketing clinical studies. Rochester, NY (PRWEB) May 20, 2014 polyDNA’s latest May 2014 survey found that 77% of participants wanted to know if the herpes virus can be deadly. The answer is yes. However, death due to a herpes infection is...


Word of the Day
cenobite
  • One of a religious order living in a convent or in community; a monk: opposed to anchoret or hermit (one who lives in solitude).
  • A social bee.
This word comes from the Latin 'coenobium,' convent, which comes from the Greek 'koinobios,' living in community.
Related